Mark J. Tarr, President & CEO at Encompass Health Corp (EHC), sold 150,000 shares at $111.89 ($16.7M) on 2026-02-11, disclosed to the SEC on 2026-02-12.
Seasonal sale ($16.7M) by President & CEO — this insider has traded EHC in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $108.03 | 16,216 | $1.8M | 10.5% |
| 2 | $108.80 | 13,231 | $1.4M | 8.6% |
| 3 | $110.07 | 15,584 | $1.7M | 10.2% |
| 4 | $110.92 | 10,954 | $1.2M | 7.3% |
| 5 | $111.89 | 6,057 | $678K | 4.0% |
| 6 | $113.09 | 87,745 |
| $9.9M |
| 59.3% |
| 7 | $113.58 | 213 | $24K | 0.1% |
| Total | $111.64 avg | 150,000 | $16.7M | 100% |
| Filing → |
| EHC | SELL | 2024-05-01 | $7.5M | — | Filing → |
| EHC | SELL | 2023-08-17 | $3.6M | — | Filing → |
| EHC | SELL | 2022-08-19 | $2.2M | — | Filing → |